OK Biotech Co., Ltd. (4155.TW)
TWD 20.9
(-0.71%)
TWD 20.9
(-0.71%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 394.04 Million TWD | -6.83% |
| 2022 | 422.94 Million TWD | 12.59% |
| 2021 | 375.63 Million TWD | 7.61% |
| 2020 | 349.06 Million TWD | -4.47% |
| 2019 | 365.39 Million TWD | 34.07% |
| 2018 | 272.54 Million TWD | 49.07% |
| 2017 | 182.83 Million TWD | 12.84% |
| 2016 | 162.02 Million TWD | -34.92% |
| 2015 | 248.97 Million TWD | 4.23% |
| 2014 | 238.86 Million TWD | -8.1% |
| 2013 | 259.92 Million TWD | 118.56% |
| 2012 | 118.92 Million TWD | 3.47% |
| 2011 | 114.94 Million TWD | 53.35% |
| 2010 | 74.95 Million TWD | 89.02% |
| 2009 | 39.65 Million TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 402.25 Million TWD | 2.08% |
| 2024 Q2 | 490.07 Million TWD | 21.83% |
| 2023 Q4 | 394.04 Million TWD | 2.28% |
| 2023 Q2 | 366.32 Million TWD | -9.91% |
| 2023 Q3 | 385.26 Million TWD | 5.17% |
| 2023 FY | 394.04 Million TWD | -6.83% |
| 2023 Q1 | 406.6 Million TWD | -3.86% |
| 2022 Q4 | 422.94 Million TWD | 6.66% |
| 2022 FY | 422.94 Million TWD | 12.59% |
| 2022 Q1 | 351.69 Million TWD | -6.37% |
| 2022 Q2 | 348.4 Million TWD | -0.94% |
| 2022 Q3 | 396.54 Million TWD | 13.82% |
| 2021 Q3 | 367.31 Million TWD | -7.07% |
| 2021 Q4 | 375.63 Million TWD | 2.27% |
| 2021 FY | 375.63 Million TWD | 7.61% |
| 2021 Q1 | 383.75 Million TWD | 9.94% |
| 2021 Q2 | 395.26 Million TWD | 3.0% |
| 2020 Q3 | 383.67 Million TWD | 1.59% |
| 2020 Q2 | 377.67 Million TWD | 8.42% |
| 2020 Q4 | 349.06 Million TWD | -9.02% |
| 2020 Q1 | 348.33 Million TWD | -4.67% |
| 2020 FY | 349.06 Million TWD | -4.47% |
| 2019 Q3 | 365.57 Million TWD | 7.29% |
| 2019 Q4 | 365.39 Million TWD | -0.05% |
| 2019 Q1 | 290.95 Million TWD | 6.75% |
| 2019 Q2 | 340.72 Million TWD | 17.11% |
| 2019 FY | 365.39 Million TWD | 34.07% |
| 2018 Q2 | 223.48 Million TWD | 12.07% |
| 2018 FY | 272.54 Million TWD | 49.07% |
| 2018 Q1 | 199.41 Million TWD | 9.07% |
| 2018 Q4 | 272.54 Million TWD | 18.57% |
| 2018 Q3 | 229.86 Million TWD | 2.85% |
| 2017 FY | 182.83 Million TWD | 12.84% |
| 2017 Q4 | 182.83 Million TWD | -10.22% |
| 2017 Q3 | 203.65 Million TWD | -3.6% |
| 2017 Q2 | 211.26 Million TWD | 10.5% |
| 2017 Q1 | 191.18 Million TWD | 17.99% |
| 2016 Q4 | 162.02 Million TWD | 0.0% |
| 2016 Q1 | - TWD | -100.0% |
| 2016 FY | 162.02 Million TWD | -34.92% |
| 2016 Q2 | 240.87 Million TWD | 0.0% |
| 2015 Q1 | 266.74 Million TWD | 11.67% |
| 2015 Q3 | 248.97 Million TWD | -6.66% |
| 2015 Q2 | 266.74 Million TWD | 0.0% |
| 2015 FY | 248.97 Million TWD | 4.23% |
| 2015 Q4 | 248.97 Million TWD | 0.0% |
| 2014 Q1 | 279.1 Million TWD | 7.38% |
| 2014 FY | 238.86 Million TWD | -8.1% |
| 2014 Q4 | 238.86 Million TWD | 0.0% |
| 2014 Q3 | 238.86 Million TWD | -14.42% |
| 2014 Q2 | 279.1 Million TWD | 0.0% |
| 2013 Q1 | 150.15 Million TWD | 26.26% |
| 2013 Q2 | 150.15 Million TWD | 0.0% |
| 2013 FY | 259.92 Million TWD | 118.56% |
| 2013 Q4 | 259.92 Million TWD | 0.0% |
| 2013 Q3 | 259.92 Million TWD | 73.1% |
| 2012 Q4 | 118.92 Million TWD | 0.0% |
| 2012 Q2 | 109.17 Million TWD | 0.0% |
| 2012 Q3 | 118.92 Million TWD | 8.93% |
| 2012 FY | 118.92 Million TWD | 3.47% |
| 2011 FY | 114.94 Million TWD | 53.35% |
| 2011 Q2 | 90.44 Million TWD | 0.0% |
| 2011 Q4 | 114.94 Million TWD | 0.0% |
| 2010 FY | 74.95 Million TWD | 89.02% |
| 2010 Q4 | 74.95 Million TWD | 0.0% |
| 2009 FY | 39.65 Million TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Excelsior Medical Co., Ltd. | 1.24 Billion TWD | 68.411% |
| Apex Medical Corp. | 420.28 Million TWD | 6.244% |
| Applied BioCode Corporation | 174.97 Million TWD | -125.203% |